Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. CMOPF Peers
See (CMOPF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CMOPF | $55.00 | N/A | 880.8M | 5.96 | $9.23 | +3.48% |
| RHHBF | $339.00 | N/A | 255.9B | 27.03 | $12.54 | +3.25% |
| RHHVF | $316.20 | -0.25% | 255.5B | 25.30 | $12.50 | +3.47% |
| RHHBY | $39.30 | -0.53% | 253.9B | 25.03 | $1.57 | +3.46% |
| AZNCF | $143.98 | +2.11% | 223.3B | 28.97 | $4.97 | +2.16% |
| NVSEF | $112.29 | +1.21% | 213.1B | 17.41 | $6.45 | +3.52% |
| SNYNF | $103.39 | +1.02% | 126B | 18.30 | $5.65 | +4.19% |
| BMYMP | $790.00 | N/A | 95.3B | 3511.11 | $0.23 | +0.13% |
| CHGCF | $55.52 | N/A | 91.4B | 32.09 | $1.73 | +0.01% |
| CHGCY | $25.90 | -2.37% | 85.2B | 29.77 | $0.87 | +0.94% |
Stock Comparison
CMOPF vs RHHBF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, RHHBF has a market cap of 255.9B. Regarding current trading prices, CMOPF is priced at $55.00, while RHHBF trades at $339.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas RHHBF's P/E ratio is 27.03. In terms of profitability, CMOPF's ROE is +0.14%, compared to RHHBF's ROE of +0.35%. Regarding short-term risk, CMOPF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs RHHVF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, RHHVF has a market cap of 255.5B. Regarding current trading prices, CMOPF is priced at $55.00, while RHHVF trades at $316.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas RHHVF's P/E ratio is 25.30. In terms of profitability, CMOPF's ROE is +0.14%, compared to RHHVF's ROE of +0.35%. Regarding short-term risk, CMOPF is more volatile compared to RHHVF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs RHHBY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, RHHBY has a market cap of 253.9B. Regarding current trading prices, CMOPF is priced at $55.00, while RHHBY trades at $39.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas RHHBY's P/E ratio is 25.03. In terms of profitability, CMOPF's ROE is +0.14%, compared to RHHBY's ROE of +0.35%. Regarding short-term risk, CMOPF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs AZNCF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, AZNCF has a market cap of 223.3B. Regarding current trading prices, CMOPF is priced at $55.00, while AZNCF trades at $143.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas AZNCF's P/E ratio is 28.97. In terms of profitability, CMOPF's ROE is +0.14%, compared to AZNCF's ROE of +0.19%. Regarding short-term risk, CMOPF is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs NVSEF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, NVSEF has a market cap of 213.1B. Regarding current trading prices, CMOPF is priced at $55.00, while NVSEF trades at $112.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas NVSEF's P/E ratio is 17.41. In terms of profitability, CMOPF's ROE is +0.14%, compared to NVSEF's ROE of +0.31%. Regarding short-term risk, CMOPF is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs SNYNF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, SNYNF has a market cap of 126B. Regarding current trading prices, CMOPF is priced at $55.00, while SNYNF trades at $103.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas SNYNF's P/E ratio is 18.30. In terms of profitability, CMOPF's ROE is +0.14%, compared to SNYNF's ROE of +0.10%. Regarding short-term risk, CMOPF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs BMYMP Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, BMYMP has a market cap of 95.3B. Regarding current trading prices, CMOPF is priced at $55.00, while BMYMP trades at $790.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas BMYMP's P/E ratio is 3511.11. In terms of profitability, CMOPF's ROE is +0.14%, compared to BMYMP's ROE of +0.32%. Regarding short-term risk, CMOPF is more volatile compared to BMYMP. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs CHGCF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, CHGCF has a market cap of 91.4B. Regarding current trading prices, CMOPF is priced at $55.00, while CHGCF trades at $55.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas CHGCF's P/E ratio is 32.09. In terms of profitability, CMOPF's ROE is +0.14%, compared to CHGCF's ROE of +0.17%. Regarding short-term risk, CMOPF is more volatile compared to CHGCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs CHGCY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, CHGCY has a market cap of 85.2B. Regarding current trading prices, CMOPF is priced at $55.00, while CHGCY trades at $25.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas CHGCY's P/E ratio is 29.77. In terms of profitability, CMOPF's ROE is +0.14%, compared to CHGCY's ROE of +0.17%. Regarding short-term risk, CMOPF is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs GLAXF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, GLAXF has a market cap of 75.8B. Regarding current trading prices, CMOPF is priced at $55.00, while GLAXF trades at $18.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas GLAXF's P/E ratio is 18.16. In terms of profitability, CMOPF's ROE is +0.14%, compared to GLAXF's ROE of +0.22%. Regarding short-term risk, CMOPF is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs DSNKY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, DSNKY has a market cap of 51.5B. Regarding current trading prices, CMOPF is priced at $55.00, while DSNKY trades at $27.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas DSNKY's P/E ratio is 25.01. In terms of profitability, CMOPF's ROE is +0.14%, compared to DSNKY's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs DSKYF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, DSKYF has a market cap of 50.4B. Regarding current trading prices, CMOPF is priced at $55.00, while DSKYF trades at $26.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas DSKYF's P/E ratio is 24.99. In terms of profitability, CMOPF's ROE is +0.14%, compared to DSKYF's ROE of +0.11%. Regarding short-term risk, CMOPF is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs BAYRY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, BAYRY has a market cap of 27.5B. Regarding current trading prices, CMOPF is priced at $55.00, while BAYRY trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas BAYRY's P/E ratio is -7.44. In terms of profitability, CMOPF's ROE is +0.14%, compared to BAYRY's ROE of -0.08%. Regarding short-term risk, CMOPF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs OTSKY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, OTSKY has a market cap of 24.8B. Regarding current trading prices, CMOPF is priced at $55.00, while OTSKY trades at $23.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas OTSKY's P/E ratio is 10.34. In terms of profitability, CMOPF's ROE is +0.14%, compared to OTSKY's ROE of +0.03%. Regarding short-term risk, CMOPF is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs OTSKF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, OTSKF has a market cap of 24.7B. Regarding current trading prices, CMOPF is priced at $55.00, while OTSKF trades at $47.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas OTSKF's P/E ratio is 10.41. In terms of profitability, CMOPF's ROE is +0.14%, compared to OTSKF's ROE of +0.03%. Regarding short-term risk, CMOPF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs ORINY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, ORINY has a market cap of 18.5B. Regarding current trading prices, CMOPF is priced at $55.00, while ORINY trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas ORINY's P/E ratio is 23.58. In terms of profitability, CMOPF's ROE is +0.14%, compared to ORINY's ROE of +0.37%. Regarding short-term risk, CMOPF is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs ALPMY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, ALPMY has a market cap of 17.3B. Regarding current trading prices, CMOPF is priced at $55.00, while ALPMY trades at $9.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas ALPMY's P/E ratio is 48.30. In terms of profitability, CMOPF's ROE is +0.14%, compared to ALPMY's ROE of +0.01%. Regarding short-term risk, CMOPF is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs ALPMF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, ALPMF has a market cap of 17.2B. Regarding current trading prices, CMOPF is priced at $55.00, while ALPMF trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas ALPMF's P/E ratio is 48.05. In terms of profitability, CMOPF's ROE is +0.14%, compared to ALPMF's ROE of +0.01%. Regarding short-term risk, CMOPF is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs GIKLY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, GIKLY has a market cap of 13.4B. Regarding current trading prices, CMOPF is priced at $55.00, while GIKLY trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas GIKLY's P/E ratio is 38.85. In terms of profitability, CMOPF's ROE is +0.14%, compared to GIKLY's ROE of +0.03%. Regarding short-term risk, CMOPF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs RCDTF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, RCDTF has a market cap of 11.5B. Regarding current trading prices, CMOPF is priced at $55.00, while RCDTF trades at $56.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas RCDTF's P/E ratio is 24.80. In terms of profitability, CMOPF's ROE is +0.14%, compared to RCDTF's ROE of +0.22%. Regarding short-term risk, CMOPF is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs CSPCY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, CSPCY has a market cap of 10B. Regarding current trading prices, CMOPF is priced at $55.00, while CSPCY trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas CSPCY's P/E ratio is 17.30. In terms of profitability, CMOPF's ROE is +0.14%, compared to CSPCY's ROE of +0.18%. Regarding short-term risk, CMOPF is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs CHJTF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, CHJTF has a market cap of 9.3B. Regarding current trading prices, CMOPF is priced at $55.00, while CHJTF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas CHJTF's P/E ratio is 16.20. In terms of profitability, CMOPF's ROE is +0.14%, compared to CHJTF's ROE of +0.18%. Regarding short-term risk, CMOPF is less volatile compared to CHJTF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs KYKOF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, KYKOF has a market cap of 8B. Regarding current trading prices, CMOPF is priced at $55.00, while KYKOF trades at $15.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas KYKOF's P/E ratio is 22.40. In terms of profitability, CMOPF's ROE is +0.14%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs HAWPY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, HAWPY has a market cap of 8B. Regarding current trading prices, CMOPF is priced at $55.00, while HAWPY trades at $35.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas HAWPY's P/E ratio is 17.89. In terms of profitability, CMOPF's ROE is +0.14%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs ORINF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, ORINF has a market cap of 6.8B. Regarding current trading prices, CMOPF is priced at $55.00, while ORINF trades at $48.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas ORINF's P/E ratio is 19.70. In terms of profitability, CMOPF's ROE is +0.14%, compared to ORINF's ROE of +0.37%. Regarding short-term risk, CMOPF is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs GIFOF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, GIFOF has a market cap of 6.7B. Regarding current trading prices, CMOPF is priced at $55.00, while GIFOF trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas GIFOF's P/E ratio is 31.73. In terms of profitability, CMOPF's ROE is +0.14%, compared to GIFOF's ROE of +0.03%. Regarding short-term risk, CMOPF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs GIFLF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, GIFLF has a market cap of 6.5B. Regarding current trading prices, CMOPF is priced at $55.00, while GIFLF trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas GIFLF's P/E ratio is 40.19. In terms of profitability, CMOPF's ROE is +0.14%, compared to GIFLF's ROE of +0.03%. Regarding short-term risk, CMOPF is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs DPHAY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CMOPF is priced at $55.00, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CMOPF's ROE is +0.14%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CMOPF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs OPHLY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, OPHLY has a market cap of 5B. Regarding current trading prices, CMOPF is priced at $55.00, while OPHLY trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas OPHLY's P/E ratio is 14.14. In terms of profitability, CMOPF's ROE is +0.14%, compared to OPHLY's ROE of +0.10%. Regarding short-term risk, CMOPF is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs OPHLF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, OPHLF has a market cap of 4.9B. Regarding current trading prices, CMOPF is priced at $55.00, while OPHLF trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas OPHLF's P/E ratio is 13.84. In terms of profitability, CMOPF's ROE is +0.14%, compared to OPHLF's ROE of +0.10%. Regarding short-term risk, CMOPF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs SNPHY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, SNPHY has a market cap of 3.8B. Regarding current trading prices, CMOPF is priced at $55.00, while SNPHY trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas SNPHY's P/E ratio is 14.71. In terms of profitability, CMOPF's ROE is +0.14%, compared to SNPHY's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs SNPHF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, SNPHF has a market cap of 3.8B. Regarding current trading prices, CMOPF is priced at $55.00, while SNPHF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas SNPHF's P/E ratio is 15.28. In terms of profitability, CMOPF's ROE is +0.14%, compared to SNPHF's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs PTKFF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, PTKFF has a market cap of 3.4B. Regarding current trading prices, CMOPF is priced at $55.00, while PTKFF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CMOPF's ROE is +0.14%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs VRBCF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, VRBCF has a market cap of 2.9B. Regarding current trading prices, CMOPF is priced at $55.00, while VRBCF trades at $346.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas VRBCF's P/E ratio is 17.61. In terms of profitability, CMOPF's ROE is +0.14%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, CMOPF is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs HAWPF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, HAWPF has a market cap of 2.1B. Regarding current trading prices, CMOPF is priced at $55.00, while HAWPF trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas HAWPF's P/E ratio is 11.75. In terms of profitability, CMOPF's ROE is +0.14%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs LYPHF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, LYPHF has a market cap of 1B. Regarding current trading prices, CMOPF is priced at $55.00, while LYPHF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas LYPHF's P/E ratio is 13.40. In terms of profitability, CMOPF's ROE is +0.14%, compared to LYPHF's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs TGRNF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, TGRNF has a market cap of 790.8M. Regarding current trading prices, CMOPF is priced at $55.00, while TGRNF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas TGRNF's P/E ratio is 10.29. In terms of profitability, CMOPF's ROE is +0.14%, compared to TGRNF's ROE of +0.09%. Regarding short-term risk, CMOPF is less volatile compared to TGRNF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs JCRRF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, JCRRF has a market cap of 556.8M. Regarding current trading prices, CMOPF is priced at $55.00, while JCRRF trades at $4.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas JCRRF's P/E ratio is -228.50. In terms of profitability, CMOPF's ROE is +0.14%, compared to JCRRF's ROE of -0.01%. Regarding short-term risk, CMOPF is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs MAYNF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, MAYNF has a market cap of 307.9M. Regarding current trading prices, CMOPF is priced at $55.00, while MAYNF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas MAYNF's P/E ratio is -3.79. In terms of profitability, CMOPF's ROE is +0.14%, compared to MAYNF's ROE of -0.35%. Regarding short-term risk, CMOPF is less volatile compared to MAYNF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs PTKFY Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, PTKFY has a market cap of 20.5M. Regarding current trading prices, CMOPF is priced at $55.00, while PTKFY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas PTKFY's P/E ratio is 20.22. In terms of profitability, CMOPF's ROE is +0.14%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs PSYGF Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, PSYGF has a market cap of 1.1M. Regarding current trading prices, CMOPF is priced at $55.00, while PSYGF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas PSYGF's P/E ratio is -0.02. In terms of profitability, CMOPF's ROE is +0.14%, compared to PSYGF's ROE of +2.78%. Regarding short-term risk, CMOPF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.
CMOPF vs CRXTQ Comparison
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 880.8M. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, CMOPF is priced at $55.00, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of 5.96, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, CMOPF's ROE is +0.14%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, CMOPF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.